233 related articles for article (PubMed ID: 22469977)
1. Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model.
Alikhani N; Ferguson RD; Novosyadlyy R; Gallagher EJ; Scheinman EJ; Yakar S; LeRoith D
Oncogene; 2013 Feb; 32(8):961-7. PubMed ID: 22469977
[TBL] [Abstract][Full Text] [Related]
2. Silencing vimentin expression decreases pulmonary metastases in a pre-diabetic mouse model of mammary tumor progression.
Zelenko Z; Gallagher EJ; Tobin-Hess A; Belardi V; Rostoker R; Blank J; Dina Y; LeRoith D
Oncogene; 2017 Mar; 36(10):1394-1403. PubMed ID: 27568979
[TBL] [Abstract][Full Text] [Related]
3. Hyperinsulinemia enhances c-Myc-mediated mammary tumor development and advances metastatic progression to the lung in a mouse model of type 2 diabetes.
Ferguson RD; Novosyadlyy R; Fierz Y; Alikhani N; Sun H; Yakar S; Leroith D
Breast Cancer Res; 2012 Jan; 14(1):R8. PubMed ID: 22226054
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting PI3K reduces mammary tumor growth and induces hyperglycemia in a mouse model of insulin resistance and hyperinsulinemia.
Gallagher EJ; Fierz Y; Vijayakumar A; Haddad N; Yakar S; LeRoith D
Oncogene; 2012 Jul; 31(27):3213-22. PubMed ID: 22037215
[TBL] [Abstract][Full Text] [Related]
5. Breast-cancer-associated metastasis is significantly increased in a model of autoimmune arthritis.
Das Roy L; Pathangey LB; Tinder TL; Schettini JL; Gruber HE; Mukherjee P
Breast Cancer Res; 2009; 11(4):R56. PubMed ID: 19643025
[TBL] [Abstract][Full Text] [Related]
6. ErbB3 ablation impairs PI3K/Akt-dependent mammary tumorigenesis.
Cook RS; Garrett JT; Sánchez V; Stanford JC; Young C; Chakrabarty A; Rinehart C; Zhang Y; Wu Y; Greenberger L; Horak ID; Arteaga CL
Cancer Res; 2011 Jun; 71(11):3941-51. PubMed ID: 21482676
[TBL] [Abstract][Full Text] [Related]
7. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers.
Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J
Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639
[TBL] [Abstract][Full Text] [Related]
8. Syngeneic mouse mammary carcinoma cell lines: two closely related cell lines with divergent metastatic behavior.
Borowsky AD; Namba R; Young LJ; Hunter KW; Hodgson JG; Tepper CG; McGoldrick ET; Muller WJ; Cardiff RD; Gregg JP
Clin Exp Metastasis; 2005; 22(1):47-59. PubMed ID: 16132578
[TBL] [Abstract][Full Text] [Related]
9. N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation.
Hulit J; Suyama K; Chung S; Keren R; Agiostratidou G; Shan W; Dong X; Williams TM; Lisanti MP; Knudsen K; Hazan RB
Cancer Res; 2007 Apr; 67(7):3106-16. PubMed ID: 17409417
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
11. Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
Rowson-Hodel AR; Wald JH; Hatakeyama J; O'Neal WK; Stonebraker JR; VanderVorst K; Saldana MJ; Borowsky AD; Sweeney C; Carraway KL
Oncogene; 2018 Jan; 37(2):197-207. PubMed ID: 28892049
[TBL] [Abstract][Full Text] [Related]
12. Mena deficiency delays tumor progression and decreases metastasis in polyoma middle-T transgenic mouse mammary tumors.
Roussos ET; Wang Y; Wyckoff JB; Sellers RS; Wang W; Li J; Pollard JW; Gertler FB; Condeelis JS
Breast Cancer Res; 2010; 12(6):R101. PubMed ID: 21108830
[TBL] [Abstract][Full Text] [Related]
13. Attenuated transforming growth factor beta signaling promotes metastasis in a model of HER2 mammary carcinogenesis.
Novitskiy SV; Forrester E; Pickup MW; Gorska AE; Chytil A; Aakre M; Polosukhina D; Owens P; Yusupova DR; Zhao Z; Ye F; Shyr Y; Moses HL
Breast Cancer Res; 2014 Oct; 16(5):425. PubMed ID: 25280532
[TBL] [Abstract][Full Text] [Related]
14. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis.
Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL
Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643
[TBL] [Abstract][Full Text] [Related]
15. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways.
Nasser MW; Qamri Z; Deol YS; Ravi J; Powell CA; Trikha P; Schwendener RA; Bai XF; Shilo K; Zou X; Leone G; Wolf R; Yuspa SH; Ganju RK
Cancer Res; 2012 Feb; 72(3):604-15. PubMed ID: 22158945
[TBL] [Abstract][Full Text] [Related]
16. Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.
David M; Ribeiro J; Descotes F; Serre CM; Barbier M; Murone M; Clézardin P; Peyruchaud O
Int J Oncol; 2012 Apr; 40(4):1133-41. PubMed ID: 22200658
[TBL] [Abstract][Full Text] [Related]
17. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis.
Calvo A; Catena R; Noble MS; Carbott D; Gil-Bazo I; Gonzalez-Moreno O; Huh JI; Sharp R; Qiu TH; Anver MR; Merlino G; Dickson RB; Johnson MD; Green JE
Oncogene; 2008 Sep; 27(40):5373-84. PubMed ID: 18504437
[TBL] [Abstract][Full Text] [Related]
18. Targeting heparanase to the mammary epithelium enhances mammary gland development and promotes tumor growth and metastasis.
Boyango I; Barash U; Fux L; Naroditsky I; Ilan N; Vlodavsky I
Matrix Biol; 2018 Jan; 65():91-103. PubMed ID: 28916201
[TBL] [Abstract][Full Text] [Related]
19. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.
Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK
Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101
[TBL] [Abstract][Full Text] [Related]
20. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
